-
Abatacept, sold
under the
brand name Orencia, is a
medication used to
treat autoimmune diseases like
rheumatoid arthritis, by
interfering with the immune...
- (INN)
abagovomab (INN)
abamectin (INN)
abanoquil (INN)
abarelix (INN)
abatacept (USAN)
Abasol Abbokinase abciximab (INN)
abecarnil (INN)
Abecma abediterol...
- A
study reported in 2016
treated a
Korean CHAI
disease patient with
abatacept,
which is a
fusion protein of CTLA-4 and an antibody, and was able to...
- label), IMO-8400, an
antagonist of Toll-like
receptor 7,8 and 9 (Ph II),
abatacept (Phase IV, open label), and
sodium thiosulfate (Phase II). "Dermatomyositis"...
-
suppressing regimens, such as
calcineurin inhibitors. It
differs from
abatacept (Orencia) by only two
amino acids.[medical
citation needed] Belatacept...
- upadacitinib. SELECT-CHOICE was a
phase III
trial comparing upadacitinib and
abatacept in 612
people whose rheumatoid arthritis did not
respond to
biologic disease-modifying...
- TNF
inhibitors (certolizumab, adalimumab,
infliximab and etanercept),
abatacept, anakinra, and auranofin. Additionally,
rituximab and
tocilizumab are...
- USAN/INN
Trade name
Indication Technology Mechanism of
action abatacept Orencia rheumatoid arthritis immunoglobin CTLA-4
fusion protein T-cell deactivation...
-
Mycophenolic acid L04AA15
Alefacept L04AA19
Gusperimus L04AA22
Abetimus L04AA24
Abatacept L04AA28
Belatacept L04AA32
Apremilast L04AA40
Cladribine L04AA41 Imlifidase...
- Drug
Mechanism Type
abatacept T-cell
costimulatory signal inhibitor bDMARD adalimumab TNF
inhibitor bDMARD anakinra IL-1
receptor antagonist bDMARD apremilast...
